Justin Ray Pedigo1, Charles F Seifert2. 1. Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, University Medical Center, Lubbock, TX, United States. 2. Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, University Medical Center, Lubbock, TX, United States. Electronic address: charles.seifert@ttuhsc.edu.
Abstract
OBJECTIVE: To determine the rate of patients visiting the emergency department who are at risk of opioid overdose. METHODS: The electronic records of a 412 bed tertiary care county teaching hospital were searched for emergency department (ED) visits from January 1, 2013 to October 31, 2016 to find patients on at least 100mg morphine equivalents (MME) of oral opioid therapy, or an opioid in combination with a benzodiazepine. Records were also searched for patients with a positive urinalysis for opioids when no opioid was present on their home medication list. Medication reconciliations were searched for patients at risk of opioid overdose who were subsequently discharged on naloxone. RESULTS: An analysis of 2521 patients visiting the ED was performed, and the overall rate of risk of opioid overdose increased from 25.84% to 47.41% (p<0.0001) in patients meeting inclusion criteria from 2013 to 2016. For patients on opioids, the rate of patients on 100 MME daily or greater increased from 9.72% to 28.24% (p<0.0001) from 2013 to 2016. The rate of patients on opioid therapy in combination with benzodiazepine therapy did not change significantly from 2013 to 2016. When comparing patients at risk of opioid overdose to total emergency department visits, we found the rate of at risk patients increased significantly from 0.12% to 0.56% (p<0.0001) from 2013 to 2016. CONCLUSIONS: The rate of patients visiting the emergency department at risk of opioid overdose increased significantly from 2013 to 2016. Naloxone was not routinely prescribed to this patient cohort.
OBJECTIVE: To determine the rate of patients visiting the emergency department who are at risk of opioid overdose. METHODS: The electronic records of a 412 bed tertiary care county teaching hospital were searched for emergency department (ED) visits from January 1, 2013 to October 31, 2016 to find patients on at least 100mg morphine equivalents (MME) of oral opioid therapy, or an opioid in combination with a benzodiazepine. Records were also searched for patients with a positive urinalysis for opioids when no opioid was present on their home medication list. Medication reconciliations were searched for patients at risk of opioid overdose who were subsequently discharged on naloxone. RESULTS: An analysis of 2521 patients visiting the ED was performed, and the overall rate of risk of opioid overdose increased from 25.84% to 47.41% (p<0.0001) in patients meeting inclusion criteria from 2013 to 2016. For patients on opioids, the rate of patients on 100 MME daily or greater increased from 9.72% to 28.24% (p<0.0001) from 2013 to 2016. The rate of patients on opioid therapy in combination with benzodiazepine therapy did not change significantly from 2013 to 2016. When comparing patients at risk of opioid overdose to total emergency department visits, we found the rate of at risk patients increased significantly from 0.12% to 0.56% (p<0.0001) from 2013 to 2016. CONCLUSIONS: The rate of patients visiting the emergency department at risk of opioid overdose increased significantly from 2013 to 2016. Naloxone was not routinely prescribed to this patient cohort.
Authors: Noa Krawczyk; Matthew Eisenberg; Kristin E Schneider; Tom M Richards; B Casey Lyons; Kate Jackson; Lindsey Ferris; Jonathan P Weiner; Brendan Saloner Journal: Ann Emerg Med Date: 2019-09-09 Impact factor: 5.721
Authors: Daniel C O'Brien; Daniel Dabbs; Kathryn Dong; Paul J Veugelers; Elaine Hyshka Journal: BMC Health Serv Res Date: 2019-09-05 Impact factor: 2.655
Authors: Bertram K Woitok; Petra Büttiker; Svenja Ravioli; Georg-Christian Funk; Aristomenis K Exadaktylos; Gregor Lindner Journal: BMJ Open Date: 2020-09-25 Impact factor: 2.692